Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
barbara kruczek
(1 results)?
Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients-Real-World Experience in a Single-Center Retrospective Study and Narrative Review.
Medicina (Kaunas). 2024 Feb 26;60(3):398. doi: 10.3390/medicina60030398.
Medicina (Kaunas). 2024.
PMID: 38541124
Free PMC article.
Review.
Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study.
Domański P, Jarosińska J, Kruczyk B, Piętak M, Mydlak A, Demkow T, Kuncman Ł, Darewicz M, Sikora-Kupis B, Dumnicka P, Kucharz J.
Domański P, et al. Among authors: kruczyk b.
Contemp Oncol (Pozn). 2023;27(3):190-197. doi: 10.5114/wo.2023.133545. Epub 2023 Dec 7.
Contemp Oncol (Pozn). 2023.
PMID: 38239858
Free PMC article.
Item in Clipboard
Prognostic value of pan-immune-inflammation value and body mass index in geriatric patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first line treatment. A single-center retrospective study.
Domański P, Jarosińska J, Kruczyk B, Piętak M, Mydlak A, Demkow T, Kuncman Ł, Darewicz M, Sikora-Kupis B, Michalski W, Kucharz J.
Domański P, et al. Among authors: kruczyk b.
Contemp Oncol (Pozn). 2023;27(4):242-248. doi: 10.5114/wo.2023.134786. Epub 2024 Jan 30.
Contemp Oncol (Pozn). 2023.
PMID: 38405212
Free PMC article.
Item in Clipboard
First experience in treating advanced urothelial cancer with enfortumab vedotin. Single-centre retrospective study of patients qualified for a rescue access procedure.
Sikora-Kupis B, Domański P, Fortuniak W, Kruczyk B, Staneta S, Piętak M, Mydlak A, Demkow T, Dumnicka P, Kucharz J.
Sikora-Kupis B, et al. Among authors: kruczyk b.
Contemp Oncol (Pozn). 2023;27(4):224-229. doi: 10.5114/wo.2023.134751. Epub 2024 Feb 10.
Contemp Oncol (Pozn). 2023.
PMID: 38405211
Free PMC article.
Item in Clipboard
Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study.
Domański P, Piętak M, Kruczyk B, Jarosińska J, Mydlak A, Demkow T, Darewicz M, Sikora-Kupis B, Dumnicka P, Kamzol W, Kucharz J.
Domański P, et al. Among authors: kruczyk b.
Biomedicines. 2024 Feb 9;12(2):413. doi: 10.3390/biomedicines12020413.
Biomedicines. 2024.
PMID: 38398014
Free PMC article.
Item in Clipboard
Cite
Cite